Annual CFI
-$84.72 M
-$126.13 M-304.56%
30 April 2024
Summary:
KalVista Pharmaceuticals annual cash flow from investing activities is currently -$84.72 million, with the most recent change of -$126.13 million (-304.56%) on 30 April 2024. During the last 3 years, it has risen by +$62.94 million (+42.62%). KALV annual CFI is now -246.42% below its all-time high of $57.86 million, reached on 01 April 2022.KALV Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$37.16 M
+$163.35 M+129.45%
31 July 2024
Summary:
KalVista Pharmaceuticals quarterly cash flow from investing activities is currently $37.16 million, with the most recent change of +$163.35 million (+129.45%) on 31 July 2024. Over the past year, it has increased by +$8.61 million (+30.14%). KALV quarterly CFI is now at all-time high.KALV Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$67.17 M
+$17.55 M+20.71%
31 July 2024
Summary:
KalVista Pharmaceuticals TTM cash flow from investing activities is currently -$67.17 million, with the most recent change of +$17.55 million (+20.71%) on 31 July 2024. Over the past year, it has dropped by -$106.61 million (-270.30%). KALV TTM CFI is now -188.99% below its all-time high of $75.48 million, reached on 31 October 2022.KALV TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALV Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -304.6% | +30.1% | -270.3% |
| 3 y3 years | +42.6% | +110.6% | +47.1% |
| 5 y5 years | -22.0% | +2554.6% | +6.3% |
KALV Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -246.4% | +42.6% | at high | +129.4% | -189.0% | +47.1% |
| 5 y | 5 years | -246.4% | +42.6% | at high | +122.3% | -189.0% | +54.5% |
| alltime | all time | -246.4% | +42.6% | at high | +122.3% | -189.0% | +54.5% |
KalVista Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | - | $37.16 M(-129.5%) | -$67.17 M(-20.7%) |
| Apr 2024 | -$84.72 M(-304.6%) | -$126.19 M(+1782.8%) | -$84.72 M(-340.3%) |
| Jan 2024 | - | -$6.70 M(-123.5%) | $35.26 M(-10.6%) |
| Oct 2023 | - | $28.56 M(+45.6%) | $39.44 M(+27.3%) |
| July 2023 | - | $19.61 M(-415.8%) | $30.98 M(-25.2%) |
| Apr 2023 | $41.41 M(-28.4%) | -$6.21 M(+146.7%) | $41.41 M(-31.0%) |
| Jan 2023 | - | -$2.52 M(-112.5%) | $60.06 M(-20.4%) |
| Oct 2022 | - | $20.10 M(-33.1%) | $75.48 M(+3.4%) |
| July 2022 | - | $30.04 M(+141.6%) | $73.02 M(+26.2%) |
| Apr 2022 | - | $12.43 M(-3.6%) | $57.86 M(-147.8%) |
| Apr 2022 | $57.86 M(-139.2%) | - | - |
| Jan 2022 | - | $12.90 M(-26.9%) | -$121.06 M(-4.7%) |
| Oct 2021 | - | $17.64 M(+18.6%) | -$127.01 M(-8.2%) |
| July 2021 | - | $14.88 M(-108.9%) | -$138.29 M(-6.3%) |
| Apr 2021 | -$147.65 M(-981.4%) | -$166.48 M(-2497.2%) | -$147.65 M(-611.7%) |
| Jan 2021 | - | $6.95 M(+9.0%) | $28.86 M(-8.9%) |
| Oct 2020 | - | $6.37 M(+15.6%) | $31.68 M(+33.1%) |
| July 2020 | - | $5.51 M(-45.0%) | $23.80 M(+42.0%) |
| Apr 2020 | $16.75 M(-124.1%) | $10.03 M(+2.6%) | $16.75 M(-328.8%) |
| Jan 2020 | - | $9.77 M(-745.3%) | -$7.32 M(-89.8%) |
| Oct 2019 | - | -$1.51 M(-1.0%) | -$71.68 M(+1.8%) |
| July 2019 | - | -$1.53 M(-89.1%) | -$70.39 M(+1.4%) |
| Apr 2019 | -$69.42 M | -$14.05 M(-74.3%) | -$69.42 M(+23.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2019 | - | -$54.59 M(>+9900.0%) | -$56.46 M(+2651.4%) |
| Oct 2018 | - | -$221.00 K(-60.9%) | -$2.05 M(+9.0%) |
| July 2018 | - | -$565.00 K(-47.9%) | -$1.88 M(+31.9%) |
| Apr 2018 | -$1.43 M(-104.2%) | -$1.08 M(+495.6%) | -$1.43 M(+316.0%) |
| Jan 2018 | - | -$182.00 K(+256.9%) | -$343.00 K(+113.0%) |
| Oct 2017 | - | -$51.00 K(-53.6%) | -$161.00 K(+46.4%) |
| July 2017 | - | -$110.00 K(<-9900.0%) | -$110.00 K(-90.5%) |
| Apr 2017 | $34.06 M(<-9900.0%) | - | - |
| Sept 2016 | - | $0.00(-100.0%) | -$1.16 M(-1.8%) |
| June 2016 | - | $122.00 K(-166.3%) | -$1.18 M(-14.6%) |
| Apr 2016 | -$11.00 K(-99.2%) | - | - |
| Mar 2016 | - | -$184.00 K(-83.2%) | -$1.38 M(+0.3%) |
| Dec 2015 | -$1.37 M(+999.2%) | -$1.09 M(+5109.5%) | -$1.37 M(+286.0%) |
| Sept 2015 | - | -$21.00 K(-73.4%) | -$356.00 K(+4.1%) |
| June 2015 | - | -$79.00 K(-56.1%) | -$342.00 K(+1.2%) |
| Apr 2015 | -$125.00 K(-21.4%) | - | - |
| Mar 2015 | - | -$180.00 K(+136.8%) | -$338.00 K(+112.6%) |
| Dec 2014 | -$159.00 K(+783.3%) | -$76.00 K(+985.7%) | -$159.00 K(+91.6%) |
| Sept 2014 | - | -$7000.00(-90.7%) | -$83.00 K(+9.2%) |
| June 2014 | - | -$75.00 K(+7400.0%) | -$76.00 K(+7500.0%) |
| Mar 2014 | - | -$1000.00 | -$1000.00 |
| Dec 2013 | -$18.00 K(-80.2%) | - | - |
| Dec 2012 | -$91.00 K | - | - |
FAQ
- What is KalVista Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual CFI year-on-year change?
- What is KalVista Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly CFI year-on-year change?
- What is KalVista Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals TTM CFI year-on-year change?
What is KalVista Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of KALV is -$84.72 M
What is the all time high annual CFI for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual cash flow from investing activities is $57.86 M
What is KalVista Pharmaceuticals annual CFI year-on-year change?
Over the past year, KALV annual cash flow from investing activities has changed by -$126.13 M (-304.56%)
What is KalVista Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of KALV is $37.16 M
What is the all time high quarterly CFI for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly cash flow from investing activities is $37.16 M
What is KalVista Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, KALV quarterly cash flow from investing activities has changed by +$8.61 M (+30.14%)
What is KalVista Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of KALV is -$67.17 M
What is the all time high TTM CFI for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high TTM cash flow from investing activities is $75.48 M
What is KalVista Pharmaceuticals TTM CFI year-on-year change?
Over the past year, KALV TTM cash flow from investing activities has changed by -$106.61 M (-270.30%)